| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.21B | 3.99B | 3.99B | 3.85B | 3.30B |
| Gross Profit | 359.40M | 456.90M | 430.35M | 295.05M | 295.13M |
| EBITDA | 140.90M | 178.70M | 163.59M | 140.86M | 131.34M |
| Net Income | 47.90M | 39.30M | 36.38M | 17.71M | 37.14M |
Balance Sheet | |||||
| Total Assets | 1.35B | 1.24B | 1.29B | 1.30B | 1.17B |
| Cash, Cash Equivalents and Short-Term Investments | 150.50M | 112.00M | 126.70M | 87.22M | 140.17M |
| Total Debt | 475.30M | 449.30M | 493.29M | 544.95M | 468.13M |
| Total Liabilities | 982.20M | 919.60M | 967.77M | 990.47M | 859.48M |
| Stockholders Equity | 365.90M | 306.60M | 310.31M | 294.36M | 301.40M |
Cash Flow | |||||
| Free Cash Flow | -18.70M | 49.90M | 107.32M | 3.93M | 30.92M |
| Operating Cash Flow | 70.10M | 124.50M | 166.93M | 60.69M | 88.29M |
| Investing Cash Flow | -16.50M | -62.30M | -54.80M | -139.06M | -98.81M |
| Financing Cash Flow | -18.00M | -72.60M | -71.35M | 24.82M | 27.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.88B | 8.36 | 14.71% | 2.06% | 6.96% | 28.47% | |
76 Outperform | £1.70B | 8.95 | 9.27% | 1.62% | 0.50% | 20.52% | |
70 Outperform | £2.03B | 17.26 | 12.20% | 0.79% | 7.74% | 31.48% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | £480.47M | 3.61 | 14.17% | 7.01% | 5.67% | 22.05% |